Lin Yu-Hsin Officer/Director Holdings Report

On April 9, 2026, Lin Yu-Hsin, Chief Executive Officer and Director of BELITE BIO, INC, reported the sale of 2500, 3500, 3000, and 200 American depositary shares under a Rule 10b5-1 trading plan. The sales occurred at weighted average prices of $180.36, $181.33, and $182.40, respectively, with the final transaction at $183.00 per share. These transactions resulted in a decrease in Ms. Lin's directly held shares, with the post-transaction total being 170,934 American depositary shares. Each American depositary share represents one ordinary share of the issuer.